Understand the source comparison
Peptide Deals September 2026: Research-Grade Compounds Comparison
Growth Hormone Secretagogues (MK 677, Hexarelin) Solid-phase peptide synthesis with HPLC purification 98.0–99.5% Moderate. Sequence length allows stable long-term storage but receptor specificity demands high purity Mass spectrometry + amino-acid analysis + en
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Growth Hormone Secretagogues (MK 677, Hexarelin)
- Solid-phase peptide synthesis with HPLC purification
- 98.0–99.5%
- Moderate. Sequence length allows stable long-term storage but receptor specificity demands high purity
- Mass spectrometry + amino-acid analysis + endotoxin testing
- Acceptable for September procurement if COA specifies synthesis date within 60 days of shipment
- Metabolic Modulators (Tesofensine, Survodutide)
- Small-batch synthesis with pharmaceutical-grade precursors
- 97.5–99.0%
- High. Longer sequences and hydrophobic residues increase degradation risk during extended storage
- Full HPLC trace + COA with storage temperature log
- Only acceptable if supplier provides documented cold-chain custody from synthesis to delivery
- Neuroprotective Peptides (Cerebrolysin, P21, Dihexa)
- Controlled solid-phase synthesis with multiple purification cycles
- 98.5–99.8%
- Very High. Blood-brain barrier penetration requires precise molecular weight and sequence integrity
- Mass spec verification + sterility testing + documented synthesis timeline
- Avoid promotional batches unless supplier maintains year-round quality standards with published batch records
- Combination Formulations (CJC1295/Ipamorelin)
- Dual synthesis with controlled mixing ratios
- 97.0–98.5% per component
- Extreme. Ratio precision critical for synergistic effects; promotional batches often show component imbalance
- Individual component verification + ratio confirmation via HPLC
- Require batch-specific ratio documentation; reject promotional sources without dual-component COAs